Latest news
Loading news…
CellZome
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Heidelberg, Baden-Wurttemberg, Germany Founded 2000 51-100 employees For Profit
CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs.
CellZome was acquired by GlaxoSmithKline in 2012 for $98M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
14
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 14
- Trademarks
- 0
- Top patent class
- g01
- IT spend
- $645K
Company Info
- Founded
- 2000
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- Heidelberg, Baden-Wurttemberg, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- May 15, 2012
- Closed
- May 15, 2012
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.6
- Trend (90d)
- -3.6
Key People at CellZome
Founder
1
professional contacts at CellZome
Contact execs at CellZome →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CellZome
Loading news…
FAQs about CellZome
People who checked this page also checked these
Browse the full Acquirezy directory.